You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 275 No. 10, March 13, 1996 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Double-blind, Placebo-Controlled Trial of Desipramine for Primary Alcohol Dependence Stratified on the Presence or Absence of Major Depression

Barbara J. Mason, PhD; James H. Kocsis, MD; Eva C. Ritvo, MD; Robert B. Cutler, PhD

JAMA. 1996;275(10):761-767.


Abstract

Objective.
—To assess the use of desipramine for secondary depression in primary alcohol dependence and its effect on abstinence.

Design.
—Randomized, double-blind, placebo-controlled trial, with stratification on the presence of secondary depression.

Subjects.
—Seventy-one volunteer and referred patients with primary alcohol dependence, abstinent a median of 8 days before randomization. A subset of 28 patients had major depression secondary to alcoholism.

Setting.
—The outpatient psychiatry departments of two urban medical centers.

Intervention.
—Six months of a clinically determined dose of desipramine.

Main Outcome Measures.
—Hamilton Depression Rating Scale, and Time Line Follow Back Interview, with breath alcohol concentrations and collateral verification.

Results.
—Hamilton Depression scores of desipramine-treated depressed alcoholics decreased significantly, controlling for baseline Hamilton Depression scores (P=.04). Overall, patients were abstinent significantly longer when receiving desipramine (P=.03). Rates of relapse of depressed vs nondepressed patients, analyzed separately, were not significant, although the survival function approached significance for the depressed subgroup (P=.09). Desipramine-treated depressed patients were more satisfied and were rated as more improved.

Conclusions.
—Major depression secondary to alcohol dependence that is diagnosed after at least 1 week of abstinence can remain stable in some placebotreated alcoholics and can respond to desipramine. Treating depression secondary to alcoholism may reduce risk for drinking relapse in some patients. Use of desipramine to reduce relapse in nondepressed alcoholics is not supported.

(JAMA. 1996;275:761-767)



Author Affiliations

From the Department of Psychiatry and Behavioral Sciences, University of Miami (Fla) School of Medicine (Drs Mason, Ritvo, and Cutler), and Department of Psychiatry, Cornell University Medical College, New York, NY (Dr Kocsis).


Footnotes

Reprint requests to Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, 1400 NW10 Ave, Suite 307, Miami, FL 33136 (Dr Mason).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The alcohol withdrawal syndrome
McKeon et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:854-862.
ABSTRACT | FULL TEXT  

Depression and cardiovascular disease: healing the broken-hearted.
Whooley
JAMA 2006;295:2874-2881.
ABSTRACT | FULL TEXT  

Perceived Effectiveness of Medications Among Mental Health Service Users With and Without Alcohol Dependence
Edlund and Harris
Psychiatr. Serv. 2006;57:692-699.
ABSTRACT | FULL TEXT  

Unhealthy Alcohol Use
Saitz
NEJM 2005;352:596-607.
FULL TEXT  

Efficacy of Valproate Maintenance in Patients With Bipolar Disorder and Alcoholism: A Double-blind Placebo-Controlled Study
Salloum et al.
Arch Gen Psychiatry 2005;62:37-45.
ABSTRACT | FULL TEXT  

Pharmacotherapy in dual diagnosis
Crome and Myton
Adv. Psychiatr. Treat. 2004;10:413-424.
ABSTRACT | FULL TEXT  

Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology
Lingford-Hughes et al.
J Psychopharmacol 2004;18:293-335.
 

Prevalence and Co-occurrence of Substance Use Disorders and Independent Mood and Anxiety Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions
Grant et al.
Arch Gen Psychiatry 2004;61:807-816.
ABSTRACT | FULL TEXT  

Treatment of Depression in Patients With Alcohol or Other Drug Dependence: A Meta-analysis
Nunes and Levin
JAMA 2004;291:1887-1896.
ABSTRACT | FULL TEXT  

Mirtazapine Improves Alcohol Detoxification
Liappas et al.
J Psychopharmacol 2004;18:88-93.
ABSTRACT  

SERTRALINE FOR THE PREVENTION OF RELAPSE IN DETOXICATED ALCOHOL DEPENDENT PATIENTS WITH A COMORBID DEPRESSIVE DISORDER: A RANDOMIZED CONTROLLED TRIAL
Gual et al.
Alcohol Alcohol 2003;38:619-625.
ABSTRACT | FULL TEXT  

Major Depression in 6050 Former Drinkers: Association With Past Alcohol Dependence
Hasin and Grant
Arch Gen Psychiatry 2002;59:794-800.
ABSTRACT | FULL TEXT  

Effects of Major Depression on Remission and Relapse of Substance Dependence
Hasin et al.
Arch Gen Psychiatry 2002;59:375-380.
ABSTRACT | FULL TEXT  

A Reevaluation of the Exclusion Criteria Used in Antidepressant Efficacy Trials
Posternak et al.
Am. J. Psychiatry 2002;159:191-200.
ABSTRACT | FULL TEXT  

Treating depression complicated by substance misuse
McIntosh and Ritson
Adv. Psychiatr. Treat. 2001;7:357-364.
FULL TEXT  

A National Survey of Care for Persons With Co-occurring Mental and Substance Use Disorders
Watkins et al.
Psychiatr. Serv. 2001;52:1062-1068.
ABSTRACT | FULL TEXT  

Managing Depression in Medical Outpatients
Whooley and Simon
NEJM 2000;343:1942-1950.
FULL TEXT  

Occurrence and Management of Depression in the Context of Naltrexone Treatment of Alcoholism
Farren and O'Malley
Am. J. Psychiatry 1999;156:1258-1262.
FULL TEXT  

Drug Therapy for Alcohol Dependence
Swift
NEJM 1999;340:1482-1490.
FULL TEXT  

Identifying Patients With Depression in the Primary Care Setting: A More Efficient Method
Brody et al.
Arch Intern Med 1998;158:2469-2475.
ABSTRACT | FULL TEXT  

Management of Adults Recovering From Alcohol or Other Drug Problems: Relapse Prevention in Primary Care
Friedmann et al.
JAMA 1998;279:1227-1231.
ABSTRACT | FULL TEXT  

Antidepressant Prescribing Practices of Outpatient Psychiatrists
Olfson et al.
Arch Gen Psychiatry 1998;55:310-316.
ABSTRACT | FULL TEXT  

The Effect of Depression on Return to Drinking: A Prospective Study
Greenfield et al.
Arch Gen Psychiatry 1998;55:259-265.
ABSTRACT | FULL TEXT  

Imipramine Treatment of Opiate-Dependent Patients With Depressive Disorders: A Placebo-Controlled Trial
Nunes et al.
Arch Gen Psychiatry 1998;55:153-160.
ABSTRACT | FULL TEXT  

Drug Abuse and Addiction Treatment Research: The Next Generation
Leshner
Arch Gen Psychiatry 1997;54:691-694.
ABSTRACT  

Fluoxetine in Depressed Alcoholics: A Double-blind, Placebo-Controlled Trial
Cornelius et al.
Arch Gen Psychiatry 1997;54:700-705.
ABSTRACT  

. . . and Abstinent Alcoholics
JWatch Psychiatry 1996;1996:3-3.
FULL TEXT  

ANTIDEPRESSANT THERAPY FOR PRIMARY ALCOHOLISM
JWatch General 1996;1996:4-4.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.